Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla.

Gruber S, Frey R, Mlynárik V, Stadlbauer A, Heiden A, Kasper S, Kemp GJ, Moser E.

Invest Radiol. 2003 Jul;38(7):403-8.

PMID:
12821853
2.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
3.

[Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].

Engelhardt E, Moreira DM, Laks J, Marinho VM, Rozenthal M, Oliveira AC Jr.

Arq Neuropsiquiatr. 2001 Dec;59(4):865-70. Review. Portuguese.

4.

The role of MR spectroscopy in neurooncology.

Kozić D, Ostojić J, Bjelan M, Koprivšek K.

Prilozi. 2012;33(1):425-33. Review.

PMID:
23037188
5.

1H-MRS in autism spectrum disorders: a systematic meta-analysis.

Ipser JC, Syal S, Bentley J, Adnams CM, Steyn B, Stein DJ.

Metab Brain Dis. 2012 Sep;27(3):275-87. doi: 10.1007/s11011-012-9293-y. Epub 2012 Mar 18. Review.

PMID:
22426803
6.

Changes in cerebral metabolites in type 2 diabetes mellitus: A meta-analysis of proton magnetic resonance spectroscopy.

Wu GY, Zhang Q, Wu JL, Jing L, Tan Y, Qiu TC, Zhao J.

J Clin Neurosci. 2017 Nov;45:9-13. doi: 10.1016/j.jocn.2017.07.017. Epub 2017 Jul 29. Review.

PMID:
28765058

Supplemental Content

Support Center